Home > Insider Trading > Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Iovance Biotherapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. My name is Gigi and I will be your operator for today's call.

Keep Reading →

March 2nd, 2023 - News Transcripts

12 Stocks Insiders are Buying Now

Investing in stocks that insiders are buying can sometimes lead to unexpected gains.

Keep Reading →

December 16th, 2022 - Hedge Funds News

5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

In this article, we will take a look at the 5 cheap small-cap stocks to buy before the next breakout.

Keep Reading →

December 12th, 2022 - Hedge Funds News

11 Best Very Cheap Stocks To Buy Now According To Hedge Funds

In this article, we discuss the 11 best very cheap stocks to buy according to hedge funds.

Keep Reading →

October 27th, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: Ken Griffin, Cathie Wood, Kenneth Tropin, Elliott Associates, Tiger Global Management, Coatue Management, Cable One Inc (CABO), Iovance Biotherapeutics, Inc. (IOVA), and More

Tiger Global Management rode the tech boom like no other investment firm. It was funding more startups than any other U.S.

Keep Reading →

June 6th, 2022 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Ray Dalio, David Tepper, Sanjay Shah, Deerfield Management, Coatue Management, Dicks Sporting Goods Inc (DKS), and More

Like most so-called Tiger Cubs, the tech-focused hedge fund Coatue has lost significant money this year.

Keep Reading →

June 3rd, 2022 - Hedge Funds Insider Trading

Did The Smart Money Get Iovance Biotherapeutics, Inc. (IOVA) Right?

Technology stocks had a lousy start to 2022. QQQ lost 9% of its value in January. Pandemic winners are getting crushed while energy stocks are surging.

Keep Reading →

February 7th, 2022 - Hedge Funds News

Hedge Funds Are Betting On Iovance Biotherapeutics, Inc. (IOVA)

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.

Keep Reading →

December 9th, 2021 - Hedge Funds News